CBD Class-Action Litigants Watching For Retroactive Effects In US FDA’s Awaited Rulemaking
Even in the “highly unlikely event” that the FDA does make CBD supplements legal, it will not do so retroactively, according to plaintiffs against CV Sciences in California’s Central District. However, the federal court, which also is hearing a similar case against competitor Charlotte’s Web, is not convinced.
California’s Central District refused on 3 December to restart proceedings in a proposed consumer class action against CV Sciences, Inc. concerning the legality of its cannabidiol-infused dietary supplements.
The court maintains that opportunity should be afforded for the US Food and Drug Administration to issue anticipated rulemaking on...